(2-Chloroethyl)(methyl)nitrosoamine (Mixture of Isomers)

(2-Chloroethyl)(methyl)nitrosoamine, also known as CENMA, is a highly toxic chemical compound that is used in various industrial processes. It is a nitrosamine derivative and is primarily used as a mutagenic agent in research studies to induce genetic mutations in cells and organisms. The compound is highly reactive and can easily penetrate cells, leading to DNA damage and cancer development. CENMA is primarily used in research studies to evaluate the potential risks associated with exposure to nitrosamines. It is commonly used to study the effects of genotoxicity and mutagenicity on various cell lines and animal models. The compound is also used to evaluate the efficacy of various cancer treatments, including chemotherapy and radiation therapy. CENMA is classified as a Category 1B carcinogen by the International Agency for Research on Cancer (IARC). It is known to cause cancer in humans, primarily in the lungs, liver, and gastrointestinal tract. Exposure to CENMA can occur through inhalation of contaminated air, ingestion of contaminated water or food, or direct contact with the skin. It is important to handle CENMA with extreme caution and to use appropriate safety measures to avoid exposure. Protective equipment, such as gloves, goggles, and respirators, should be worn when working with the compound. Proper disposal methods should also be followed to prevent environmental contamination.